CORDIS · 101097036 · HORIZON

ONCOSCREEN A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways

Coordinator: EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIS (EL)

With Colorectal Cancer (CRC) being accountable for 12.4% of all deaths due to cancer, and with only 14% of EU citizens participating in screening programmes, there is an urgent need for accurate, non-invasive, cost-effective screening tests based on novel technologies and an increased awareness on the disease and its detection. Furthermore, personalized approaches for screening are needed, to consider genetic and other socioeconomic variables and environmental stressors that lead to different onsets of the disease. ONCOSCREEN responds to these challenges by developing a risk-based, population…

EU contribution
€13.0M
Total cost
Period
2023-01-01 → 2026-12-31
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-RIA
Call
HORIZON-MISS-2021-CANCER-02
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

EU contribution: €13.0M awarded to the consortium. The project runs over approximately 4 years from 2023-01-01 to 2026-12-31.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-RIA funding scheme.
What is the EU contribution?
The European Commission contributes €13.0M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-MISS-2021-CANCER-02.
Who coordinates the project?
The project is coordinated by EXUS SOFTWARE MONOPROSOPI ETAIRIA PERIORISMENIS EVTHINIS (EL).
What is the project timeline?
The project runs from 2023-01-01 to 2026-12-31 — approximately 4 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101097036.